Rupshee Jain

609 total citations
17 papers, 430 citations indexed

About

Rupshee Jain is a scholar working on Molecular Biology, Biomaterials and Pharmacology. According to data from OpenAlex, Rupshee Jain has authored 17 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biomaterials and 4 papers in Pharmacology. Recurrent topics in Rupshee Jain's work include Nanoparticle-Based Drug Delivery (4 papers), Flavonoids in Medical Research (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Rupshee Jain is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Flavonoids in Medical Research (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Rupshee Jain collaborates with scholars based in India and United States. Rupshee Jain's co-authors include Asit K. Chakraborti, Sudip Samanta, Vikas Jain, Hitesh Kumar, SubbaRao V. Madhunapantula, Siddharth S. Kesharwani, Surajit Dey, Saravana Babu Chidambaram, Neha Gupta and Akash Chaurasiya and has published in prestigious journals such as Applied Microbiology and Biotechnology, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

Rupshee Jain

17 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupshee Jain India 8 183 136 67 61 60 17 430
Seul Ji Lee South Korea 13 148 0.8× 80 0.6× 21 0.3× 17 0.3× 30 0.5× 28 452
Neha Upadhyay India 15 306 1.7× 39 0.3× 85 1.3× 22 0.4× 65 1.1× 24 653
Akio Kanetoshi Japan 12 97 0.5× 157 1.2× 182 2.7× 56 0.9× 42 0.7× 19 494
Baohua Yang China 9 123 0.7× 25 0.2× 81 1.2× 21 0.3× 27 0.5× 18 473
Preetismita Borah India 9 175 1.0× 32 0.2× 49 0.7× 25 0.4× 22 0.4× 21 508
Xiaomeng Ji China 13 88 0.5× 69 0.5× 129 1.9× 14 0.2× 31 0.5× 34 420
Mesude İşcan Türkiye 12 115 0.6× 86 0.6× 192 2.9× 13 0.2× 32 0.5× 28 426
Yuan Ji China 15 217 1.2× 70 0.5× 8 0.1× 17 0.3× 66 1.1× 28 539
Krongtong Yoovathaworn Thailand 13 146 0.8× 39 0.3× 62 0.9× 34 0.6× 62 1.0× 17 529
Hanmin Li China 14 211 1.2× 58 0.4× 31 0.5× 27 0.4× 33 0.6× 36 588

Countries citing papers authored by Rupshee Jain

Since Specialization
Citations

This map shows the geographic impact of Rupshee Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupshee Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupshee Jain more than expected).

Fields of papers citing papers by Rupshee Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupshee Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupshee Jain. The network helps show where Rupshee Jain may publish in the future.

Co-authorship network of co-authors of Rupshee Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Rupshee Jain. A scholar is included among the top collaborators of Rupshee Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupshee Jain. Rupshee Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kumar, Hitesh, et al.. (2025). A review of the current status of biological effects of plant-derived therapeutics in breast cancer. Molecular Biology Reports. 52(1). 159–159. 1 indexed citations
2.
Jain, Rupshee, et al.. (2024). Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer. Therapeutic Delivery. 15(11). 871–891. 1 indexed citations
3.
Jain, Vikas, et al.. (2024). Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2387–2406. 3 indexed citations
4.
Kumar, Hitesh, et al.. (2023). Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. Pharmaceuticals. 16(2). 196–196. 60 indexed citations
5.
Shilpi, Satish, Shvetank Bhatt, Pawan Kumar Gupta, et al.. (2023). Nanosizing Approaches: Current Trends in the Solubility Enhancement of Poorly Water-soluble Drugs. Indian Journal of Pharmaceutical Education and Research. 57(3). 625–639. 1 indexed citations
6.
Kumar, Hitesh, et al.. (2023). The multifaceted role of extracellular vesicles in prostate cancer-a review. Cancer Drug Resistance. 6(3). 481–98. 2 indexed citations
7.
Bhatt, Tanvi, Hitesh Kumar, Rupshee Jain, & Vikas Jain. (2023). Emerging Applications of Electrospun Nanofibers Using Various Fabrication Techniques. Indian Journal of Pharmaceutical Education and Research. 57(3). 658–668. 6 indexed citations
8.
Mishra, Shivani B., et al.. (2023). Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery. Frontiers in Pharmacology. 14. 1101320–1101320. 13 indexed citations
9.
Kumar, Hitesh, Neha Gupta, Rupshee Jain, et al.. (2023). F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer. International Journal of Pharmaceutics. 643. 123226–123226. 5 indexed citations
10.
Kumar, Hitesh, Neha Gupta, Rupshee Jain, et al.. (2023). A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer. Journal of Advanced Research. 54. 271–292. 74 indexed citations
11.
Chand, Pallavi, Hitesh Kumar, Rupshee Jain, Atul Jain, & Vikas Jain. (2023). Flavonoids as omnipotent candidates for cancer management. South African Journal of Botany. 158. 334–346. 5 indexed citations
12.
Kumar, Hitesh, et al.. (2023). Fisetin-Loaded Nanostructured Lipid Carriers: Formulation and Evaluations against Advanced and Metastatic Melanoma. Molecular Pharmaceutics. 20(12). 6035–6055. 11 indexed citations
13.
Kumar, Hitesh, et al.. (2022). Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions. Molecular Biology Reports. 50(2). 1871–1883. 20 indexed citations
14.
15.
Gurupadayya, Bannimath, et al.. (2019). NOVEL HPTLC-DENSITOMETRIC METHOD FOR THE ESTIMATION OF TERIFLUNOMIDE IN TABLET DOSAGE FORM. International Journal of Pharmacy and Pharmaceutical Sciences. 80–84. 2 indexed citations
16.
Kashaw, Sushil K., et al.. (2011). Visible spectrophotometric method for the determination of aripiprazole in tablets. Indian Journal of Pharmaceutical Sciences. 73(1). 74–74. 18 indexed citations
17.
Samanta, Sudip, Asit K. Chakraborti, & Rupshee Jain. (1999). Degradation of phenanthrene by different bacteria: evidence for novel transformation sequences involving the formation of 1-naphthol. Applied Microbiology and Biotechnology. 53(1). 98–107. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026